KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Financing Activities (2016 - 2025)

Biogen (BIIB) has 17 years of Cash from Financing Activities data on record, last reported at -$137.0 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 1834.18% year-over-year to -$137.0 million; the TTM value through Dec 2025 reached -$301.9 million, up 55.83%, while the annual FY2025 figure was -$301.9 million, 55.83% up from the prior year.
  • Cash from Financing Activities reached -$137.0 million in Q4 2025 per BIIB's latest filing, down from -$130.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $848.6 million in Q3 2023 and bottomed at -$1.3 billion in Q3 2022.
  • Average Cash from Financing Activities over 5 years is -$233.5 million, with a median of -$86.8 million recorded in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 167.78% in 2023, down 8631.08% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $9.8 million in 2021, then crashed by 175.51% to -$7.4 million in 2022, then crashed by 8631.08% to -$646.1 million in 2023, then soared by 101.22% to $7.9 million in 2024, then plummeted by 1834.18% to -$137.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$137.0 million in Q4 2025, -$130.2 million in Q3 2025, and -$11.7 million in Q2 2025.